Literature DB >> 16879239

Toll-like receptor (TLR) 4 polymorphism Asp299Gly is not associated with disease course in Dutch sarcoidosis patients.

M Veltkamp1, J C Grutters, C H M van Moorsel, H J T Ruven, J M M van den Bosch.   

Abstract

The aetiology of sarcoidosis, a systemic disorder characterized by the formation of non-caseating granulomas in variable organs, remains enigmatic. Clarification is hampered by heterogeneity in disease phenotypes and course, due partly to the influence of a variety of genetic and environmental factors. Multiple studies have pointed towards bacteria as possible causative agents. Toll-like receptors (TLR) are innate immunity receptors important in the immune response against pathogens. TLR-4, together with CD14 and MD-2, is an essential receptor for the recognition of lipopolysaccharide (LPS), unique to the cell wall of Gram-negative bacteria. Recently, an association between TLR-4 polymorphism Asp299Gly, leading to a change in the extracellular domain of the receptor and possible hyporesponsiveness to LPS, and a chronic course of sarcoidosis was found in German patients. In the present study this polymorphism was genotyped in 156 Dutch sarcoidosis patients and 200 healthy Dutch controls using dual-labelled fluorescent oligonucleotides. No differences were found in allelic distributions between patients and controls (P = 0.79) or within the different clinical entities of the sarcoidosis group (P = 0.44). Importantly, there were no differences between the Dutch and German sarcoidosis patients (P = 0.62). However, the allelic distribution of the Asp299Gly polymorphism differed significantly between both control groups (P = 0.04). This study highlights the importance of testing a reported gene association in a distinct population when performing genetic association studies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16879239      PMCID: PMC1809680          DOI: 10.1111/j.1365-2249.2006.03127.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

1.  Determination of the TLR4 genotype using allele-specific PCR.

Authors:  E Lorenz; K L Frees; D A Schwartz
Journal:  Biotechniques       Date:  2001-07       Impact factor: 1.993

2.  Toll-like receptor 4 polymorphisms and atherogenesis.

Authors:  Graham S Cooke; Shelley Segal; Adrian V S Hill
Journal:  N Engl J Med       Date:  2002-12-12       Impact factor: 91.245

Review 3.  Problems of reporting genetic associations with complex outcomes.

Authors:  Helen M Colhoun; Paul M McKeigue; George Davey Smith
Journal:  Lancet       Date:  2003-03-08       Impact factor: 79.321

4.  Association of the ASP299GLY TLR4 polymorphism with COPD.

Authors:  Gernot Rohde; Wolfram Klein; Umut Arinir; Michaela Hagedorn; Natascha Duerig; Torsten T Bauer; Adrian Gillissen; Gerhard Schultze-Werninghaus; Jörg T Epplen
Journal:  Respir Med       Date:  2005-10-10       Impact factor: 3.415

5.  Mortality of intrathoracic sarcoidosis in referral vs population-based settings: influence of stage, ethnicity, and corticosteroid therapy.

Authors:  Jerome M Reich
Journal:  Chest       Date:  2002-01       Impact factor: 9.410

Review 6.  ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders.

Authors:  G W Hunninghake; U Costabel; M Ando; R Baughman; J F Cordier; R du Bois; A Eklund; M Kitaichi; J Lynch; G Rizzato; C Rose; O Selroos; G Semenzato; O P Sharma
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  1999-09       Impact factor: 0.670

Review 7.  Is there a role for microorganisms in the pathogenesis of sarcoidosis?

Authors:  R M du Bois; N Goh; D McGrath; P Cullinan
Journal:  J Intern Med       Date:  2003-01       Impact factor: 8.989

8.  Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis.

Authors:  Yoshinobu Eishi; Moritaka Suga; Ikuo Ishige; Daisuke Kobayashi; Tetsuo Yamada; Tamiko Takemura; Touichiro Takizawa; Morio Koike; Shoji Kudoh; Ulrich Costabel; Josune Guzman; Gianfranco Rizzato; Marcello Gambacorta; Ronald du Bois; Andrew G Nicholson; Om P Sharma; Masayuki Ando
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

9.  Single step high-throughput determination of Toll-like receptor 4 polymorphisms.

Authors:  Bas B van Rijn; Mark Roest; Arie Franx; Hein W Bruinse; Hieronymus A M Voorbij
Journal:  J Immunol Methods       Date:  2004-06       Impact factor: 2.303

10.  Toll-like receptor-4 Asp299Gly polymorphism does not influence progression of atherosclerosis in patients with familial hypercholesterolaemia.

Authors:  M G Netea; A Hijmans; S van Wissen; T J Smilde; M D Trip; B J Kullberg; T de Boo; J W M Van der Meer; J J P Kastelein; A F H Stalenhoef; A F H Stalenhorf
Journal:  Eur J Clin Invest       Date:  2004-02       Impact factor: 4.686

View more
  12 in total

1.  Linkage between Toll-like receptor (TLR) 2 promotor and intron polymorphisms: functional effects and relevance to sarcoidosis.

Authors:  M Veltkamp; P A H M Wijnen; C H M van Moorsel; G T Rijkers; H J T Ruven; M Heron; O Bekers; A M E Claessen; M Drent; J M M van den Bosch; J C Grutters
Journal:  Clin Exp Immunol       Date:  2007-06-12       Impact factor: 4.330

Review 2.  Toll like receptors in diseases of the lung.

Authors:  Melissa A Kovach; Theodore J Standiford
Journal:  Int Immunopharmacol       Date:  2011-05-30       Impact factor: 4.932

3.  Toll-like receptor (TLR)-9 genetics and function in sarcoidosis.

Authors:  M Veltkamp; C H M Van Moorsel; G T Rijkers; H J T Ruven; J M M Van Den Bosch; J C Grutters
Journal:  Clin Exp Immunol       Date:  2010-08-19       Impact factor: 4.330

4.  Giant cell formation in sarcoidosis: cell fusion or proliferation with non-division?

Authors:  T C M Th van Maarsseveen; W Vos; P J van Diest
Journal:  Clin Exp Immunol       Date:  2008-12-05       Impact factor: 4.330

5.  Study of Toll-like receptor gene loci in sarcoidosis.

Authors:  M Schürmann; R Kwiatkowski; M Albrecht; A Fischer; J Hampe; J Müller-Quernheim; E Schwinger; S Schreiber
Journal:  Clin Exp Immunol       Date:  2008-04-16       Impact factor: 4.330

6.  Polymorphisms and haplotypes in MyD88 are associated with the development of sarcoidosis: a candidate-gene association study.

Authors:  Z Daniil; V Mollaki; F Malli; A Koutsokera; K M Antoniou; P Rodopoulou; K Gourgoulianis; E Zintzaras; G Vassilopoulos
Journal:  Mol Biol Rep       Date:  2013-05-11       Impact factor: 2.316

7.  Disordered Toll-like receptor 2 responses in the pathogenesis of pulmonary sarcoidosis.

Authors:  M I Gabrilovich; J Walrath; J van Lunteren; D Nethery; M Seifu; J A Kern; C V Harding; L Tuscano; H Lee; S D Williams; W Mackay; J F Tomashefski; R F Silver
Journal:  Clin Exp Immunol       Date:  2013-09       Impact factor: 4.330

8.  Higher monocyte expression of TLR2 and TLR4, and enhanced pro-inflammatory synergy of TLR2 with NOD2 stimulation in sarcoidosis.

Authors:  Maria Wikén; Johan Grunewald; Anders Eklund; Jan Wahlström
Journal:  J Clin Immunol       Date:  2008-09-05       Impact factor: 8.317

9.  Association of the TLR4 Asp299Gly polymorphism with lung function in relation to body mass index.

Authors:  Punam Pahwa; Chandima P Karunanayake; Donna C Rennie; Yue Chen; David A Schwartz; James A Dosman
Journal:  BMC Pulm Med       Date:  2009-09-21       Impact factor: 3.317

10.  Lack of association between toll-like receptor 4 gene polymorphisms and sarcoidosis-related uveitis in Japan.

Authors:  Yuri Asukata; Masao Ota; Akira Meguro; Yoshihiko Katsuyama; Mami Ishihara; Kenichi Namba; Nobuyoshi Kitaichi; Shin-Ichiro Morimoto; Toshikatsu Kaburaki; Yasutaka Ando; Shinobu Takenaka; Hidetoshi Inoko; Shigeaki Ohno; Nobuhisa Mizuki
Journal:  Mol Vis       Date:  2009-12-10       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.